Fogelholm 1992.
Methods |
Design: randomised controlled trial Randomisation: individual. Randomisation stratified by menstrual status (regular/irregular) Trial: daily oral iron versus placebo Date of study: not stated |
|
Participants |
Setting: sports teams in Finland (athletics, basketball, handball) Malaria endemicity: not stated Included: women from sport teams aged 17 years to 31 years (mean age not reported, median age 24 years), with subclinical iron depletion (ferritin < 25 mg/mL, haemoglobin > 120 g/L) Excluded: not stated Dropouts: 2 from intervention group, none from control group Sample size: total: 31; intervention: 14, control: 17 |
|
Interventions |
Intervention: 100 mg elemental iron as ferrous sulphate Control: placebo Duration: 8 weeks |
|
Outcomes | Haemoglobin, iron status, VO2 max | |
Notes |
Compliance: not stated Conflicts of interest: not stated Funded by: grant from the Ministry of Education (presumed of Finland) |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Random permutated blocks |
Allocation concealment (selection bias) | Unclear risk | Not stated |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Placebo administered |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not reported. Exercise outcomes could be influenced by knowledge of allocation |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No attrition |
Selective reporting (reporting bias) | Unclear risk | HR and oxygen consumption data stated to be non significantly different between arms but data not shown. Lactate only shown in a figure |
Other bias | Low risk | Not evident |